20 stocks in focus today: Signature Global, IndusInd Bank, pharma, railway and power counters
From Signature Global’s ₹920-crore construction contracts to IndusInd Bank’s RBI approval for a stockbroking subsidiary, today’s watchlist features major updates across real estate, banking, pharma, railways and clean energy, with NBCC, RITES and Emcure Pharma also in focus.
We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.